Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 1.44% | 30.24 | 14.1% | $177.94m | |
| HZNP | Horizon Therapeutics Plc | -0.19% | 91.45 | 5.5% | $174.64m | |
| GWPH | GW Pharmaceuticals Plc | 0.17% | 218.36 | 6.1% | $132.57m | |
| CTLT | Catalent, Inc. | 0.86% | 109.98 | 2.1% | $128.58m | |
| BHC | Bausch Health Cos., Inc. | 1.44% | 30.24 | 0.0% | $123.31m | |
| ICLR | ICON plc | -0.81% | 196.43 | 4.2% | $121.81m | |
| UTHR | United Therapeutics Corp. | 1.75% | 202.78 | 14.1% | $98.97m | |
| JAZZ | Jazz Pharmaceuticals Plc | 1.87% | 166.37 | 2.3% | $88.00m | |
| SAVA | Cassava Sciences, Inc. | -1.00% | 35.67 | 0.0% | $69.79m | |
| ARGX | argenx SE | 1.41% | 272.78 | 0.0% | $50.95m | |
| SAGE | SAGE Therapeutics, Inc. | 5.19% | 75.67 | 7.6% | $37.98m | |
| PRGO | Perrigo Co. Plc | 0.65% | 40.41 | 6.9% | $37.14m | |
| AMRN | Amarin Corp. Plc | 0.59% | 5.11 | 1.5% | $28.81m | |
| PCRX | Pacira Biosciences, Inc. | 1.71% | 69.43 | 9.9% | $26.96m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.13% | 21.41 | 16.8% | $21.61m |
Company Profile
Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.